You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mCRC

Showing 1 - 25 of 582
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Colorectal Cancer Trial in Shanghai (Fruquintinib+mFOLFOX6/FOLFIRI)

Recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 23, 2023

Colorectal Cancer Trial (Regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 17, 2023

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Colorectal Cancer Trial in Nanjing (7-Form of Medical Tai Chi Exercise Healing for Colon cancer patients)

Recruiting
  • Colorectal Cancer
  • 7-Form of Medical Tai Chi Exercise Healing for Colon cancer patients
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 23, 2023

Fruquintinib in the Cross-line Treatment of Refractory mCRC

Recruiting
  • Fruquintinib
  • Metastatic Colorectal Cancer
  • Wuhan, Hubei, China
  • +2 more
Oct 23, 2023

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • Eye90 Microspheres
  • Grafton, New Zealand
    Auckland District Health Board
Jan 30, 2023

Overall Survival in Metastatic Colorectal Cancer (mCRC)

Completed
  • Metastatic Colorectal Cancer (mCRC)
    • Princeton, New Jersey
      Local Institution
    Jun 13, 2022

    Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)

    Recruiting
    • Metastatic Colorectal Cancer
    • mCRC
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital
    May 1, 2022

    Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,

    Recruiting
    • Metastatic Colorectal Cancer
    • +2 more
    • ctDNA and adjuvant therapy
    • ctDNA
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 22, 2022

    New Patient Stratification Tools in MSS RAS mt mCRC

    Completed
    • Advanced Colorectal Cancer
      • Heidelberg, Germany
      • +9 more
      Nov 25, 2022

      Metastatic Colorectal Cancer (mCRC) Trial in Nanjing (HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection)

      Active, not recruiting
      • Metastatic Colorectal Cancer (mCRC)
      • HLX04 100 mg in 4 ml Injection
      • Avastin 100 mg in 4 ml Injection
      • Nanjing, Jiangsu, China
        Nanjing Bayi Hospital Ethics Committee
      May 6, 2022

      Metastatic Colorectal Cancer Trial in China (HLX10/Placebo, HLX04/Avastin)

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Guangzhou, Guangdong, China
      • +3 more
      Dec 19, 2022

      Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

      Completed
      Has Results
      • Metastatic Colorectal Cancer
      • MSS
      • Heidelberg, Germany
        National Center for Tumor Diseases, University Hospital Heidelbe
      May 17, 2022

      Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,

      Terminated
      Has Results
      • Colon Cancer Liver Metastasis
      • Lyso-Thermosensitive Liposomal Doxorubicin
      • +2 more
      • Los Angeles, California
      • +3 more
      Sep 15, 2022

      Colorectal Tumors Trial in Xiamen (hypofractionation Radiotherapy, sintilimab, GM-CSF)

      Recruiting
      • Colorectal Neoplasms
      • hypofractionation Radiotherapy
      • +3 more
      • Xiamen, Fujian, China
        The First Affiliated Hospital of Xiamen University
      Mar 28, 2022

      Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Regorafenib (Stivarga, BAY73-4506)
      • Hyderabad, Andhra Pradesh, India
      • +12 more
      Jan 13, 2023

      Metastatic Colorectal Cancer Trial in Wuhan (SBRT, Fruquintinib, Cadonilimab)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • SBRT, Fruquintinib, Cadonilimab
      • Wuhan, Hubei, China
        Cancer Center, Union Hospital, Tongji Medical College, Huazhong
      Feb 18, 2023

      Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)

      Terminated
      Has Results
      • Colorectal Cancer
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Jan 10, 2022

      Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Madrid, Spain
        Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
      Oct 10, 2022

      Metastatic Colorectal Cancer Trial in Providence (Dose level 1 ONC201 625mg, Dose level 2 ONC201 500mg, Dose level 3 ONC201

      Terminated
      Has Results
      • Metastatic Colorectal Cancer
      • Dose level 1 ONC201 625mg
      • +2 more
      • Providence, Rhode Island
        Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
      May 25, 2022

      CRC Trial in Beijing (HL-085, Vemurafenib)

      Not yet recruiting
      • CRC
      • Beijing, Beijing, China
        Beijing Oncology Hospital
      Feb 6, 2022